Healthcare Jul 22, 2021 09:18 AM (GMT+8) · EqualOcean
Recently, Beijing geenga Technology Co., Ltd., a leading cancer precision medical enterprise in China, announced the completion of round C financing with a total amount of about 750 million RMB, which was invested by CCB international. The following investors include Dachen Caizhi, Jinmao capital, GGV Jiyuan capital, and many well-known institutions such as Ali health, Yuanfeng capital, CCB investment, Huajin investment, BV Baidu venture capital, Shengyu investment, Junci investment, Zhongguancun Zhongnuo fund, JINZI fund, Weiting capital, chuanghehui capital, etc. Huaxing capital is the exclusive financial consultant of this financing.